Literature DB >> 20110437

Successful treatment of IgM-mediated autoimmune hemolytic anemia with bortezomib.

Kenneth R Carson, Lee G Beckwith, Jayesh Mehta.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2010        PMID： 20110437     DOI： 10.1182/blood-2009-09-242917

Source DB:  PubMed          Journal:  Blood        ISSN： 0006-4971            Impact factor:   22.113


× No keyword cloud information.
  15 in total

Review 1.  Cold agglutinin disease.

Authors:  Sigbjørn Berentsen
Journal:  Hematology Am Soc Hematol Educ Program       Date:  2016-12-02

2.  Bortezomib decreases the magnitude of a primary humoral immune response to transfused red blood cells in a murine model.

Authors:  Prabitha Natarajan; Jingchun Liu; Manjula Santhanakrishnan; David R Gibb; Lewis M Slater; Jeanne E Hendrickson
Journal:  Transfusion       Date:  2016-10-13       Impact factor: 3.157

3.  Bortezomib-based antibody depletion for refractory autoimmune hematological diseases.

Authors:  Sumita Ratnasingam; Patricia A Walker; Huy Tran; Zane S Kaplan; James D McFadyen; Huyen Tran; Tse-Chieh Teh; Shaun Fleming; John V Catalano; Sanjeev D Chunilal; Anna Johnston; Stephen S Opat; Jake Shortt
Journal:  Blood Adv       Date:  2016-11-22

Review 4.  Treatment of autoimmune hemolytic anemias.

Authors:  Alberto Zanella; Wilma Barcellini
Journal:  Haematologica       Date:  2014-10       Impact factor: 9.941

5.  Successful treatment of refractory cold hemagglutinemia in MYD88 L265P mutation-negative Waldenström's macroglobulinemia with bortezomib.

Authors:  Mayuko Izumi; Hiroko Tsunemine; Yasuhiro Suzuki; Akihiro Tomita; Toshiko Kusumoto; Taiichi Kodaka; Kiminari Itoh; Takayuki Takahashi
Journal:  Int J Hematol       Date:  2015-03-21       Impact factor: 2.490

6.  Refractory warm IgM-mediated autoimmune hemolytic anemia associated with Churg-Strauss syndrome responsive to eculizumab and rituximab.

Authors:  Mark P Chao; Jison Hong; Christian Kunder; Laura Lester; Stanley L Schrier; Ravindra Majeti
Journal:  Am J Hematol       Date:  2014-07-11       Impact factor: 10.047

Review 7.  Red blood cell destruction in autoimmune hemolytic anemia: role of complement and potential new targets for therapy.

Authors:  Sigbjørn Berentsen; Tatjana Sundic
Journal:  Biomed Res Int       Date:  2015-01-29       Impact factor: 3.411

Review 8.  Successful treatment of severe immune hemolytic anemia after allogeneic stem cell transplantation with bortezomib: report of a case and review of literature.

Authors:  Sakura Hosoba; David L Jaye; Cynthia Cohen; John D Roback; Edmund K Waller
Journal:  Transfusion       Date:  2014-08-25       Impact factor: 3.157

Review 9.  Role of Complement in Autoimmune Hemolytic Anemia.

Authors:  Sigbjørn Berentsen
Journal:  Transfus Med Hemother       Date:  2015-09-07       Impact factor: 3.747

Review 10.  New Insights in the Pathogenesis of Autoimmune Hemolytic Anemia.

Authors:  Wilma Barcellini
Journal:  Transfus Med Hemother       Date:  2015-09-07       Impact factor: 3.747
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.